HIGHLIGHTS
- who: Elin M. V. Forsberg and colleagues from the Departments of Surgery and Oncology, Institute of Clinical Sciences, University of Gothenburg, Harry Perkins Institute of Medical Research, University of Western Australia, Perth, WA, Australia have published the article: Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs, in the Journal: (JOURNAL)
- what: The aim of this study was to assess whether CAR expression in TILs can boost tumor cell death. Since the percentage of anti-HER2 CAR positive cells was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.